Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
A Phase II Study of Maintenance With Azacitidine in MDS Patients
ClinicalTrials.gov study NCT00446303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment
ClinicalTrials.gov study NCT02269579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS
ClinicalTrials.gov study NCT07347418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
ClinicalTrials.gov study NCT05490446. IPD Sharing: NO. Countries: 13. Publications: 0.
A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS
ClinicalTrials.gov study NCT06372717. IPD Sharing: NO. Countries: 2. Publications: 0.
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
ClinicalTrials.gov study NCT02124174. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00666497. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
ClinicalTrials.gov study NCT06329999. IPD Sharing: NO. Countries: 1. Publications: 0.
Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00234143. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
ClinicalTrials.gov study NCT01010373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab With Chemotherapy in Refractory MDS
ClinicalTrials.gov study NCT03259516. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in I
ClinicalTrials.gov study NCT05891249. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03303066. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03850418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
ClinicalTrials.gov study NCT05434598. IPD Sharing: YES. Countries: 1. Publications: 0.
Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients
ClinicalTrials.gov study NCT01152346. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS
ClinicalTrials.gov study NCT06247917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS
ClinicalTrials.gov study NCT02923986. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogenic NK Cell Transfusion Azacitidine MDS-EB
ClinicalTrials.gov study NCT04599426. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00923234. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.